BackgroundMothers of preterm infants often have symptoms of anxiety and depression, recognized as risk factors for the development of cardiovascular diseases and associated with low rates of heart rate variability (HRV). This study aimed to evaluate the influence of music therapy intervention on the autonomic control of heart rate, anxiety, and depression in mothers.MethodsProspective randomized clinical trial including 21 mothers of preterms admitted to the Neonatal Intensive Care Unit of a tertiary hospital, recruited from August 2015 to September 2017, and divided into control group (CG; n = 11) and music therapy group (MTG; n = 10). Participants underwent anxiety and depression evaluation, as well as measurements of the intervals between consecutive heartbeats or RR intervals for the analysis of HRV at the first and the last weeks of hospitalization of their preterms. Music therapy sessions lasting 30–45 min were individually delivered weekly using receptive techniques. The mean and standard deviation of variables were obtained and the normality of data was analyzed using the Kolmogorov-Smirnov test. The paired sample t-test or Wilcoxon test were employed to calculate the differences between variables before and after music therapy intervention. The correlations anxiety versus heart variables and depression versus heart variables were established using Spearman correlation test. Fisher’s exact test was used to verify the differences between categorical variables. A significance level of p < 0.05 was established. Statistical analysis were performed using the Statistical Package for the Social Sciences, version 20.ResultsParticipants in MTG had an average of seven sessions of music therapy, and showed improvement in anxiety and depression scores and autonomic indexes of the time domain (p < 0.05). Significant correlations were found between depression and parasympathetic modulation using linear (r = − 0.687; p = 0.028) and nonlinear analyses (r = − 0.689; p = 0.027) in MTG.ConclusionMusic therapy had a significant and positive impact on anxiety and depression, acting on prevention of cardiovascular diseases, major threats to modern society.Trial registrationBrazilian Registry of Clinical Trials (no. RBR-3x7gz8). Retrospectively registered on November 17, 2017.
Purpose: To investigate the influence of music therapy on the reduction of fatigue in women with breast or gynecological malignant neoplasia during radiotherapy, since it is one of the most frequent side effects of this type of treatment, and may interfere with self-esteem, social activities, and quality of life. Experimental Design: Randomized controlled trial (control group [CG] and music therapy group [MTG]) to assess fatigue, quality of life, and symptoms of depression in women undergoing radiotherapy using the Functional Assessment of Cancer Therapy: Fatigue (FACT-F) version 4, Functional Assessment of Cancer Therapy–General (FACT-G) version 4, and Beck Depression Inventory in 3 separate times, namely, during the first week of radiotherapy, on the week of the intermediary phase, and during the last week of radiotherapy. Individual 30- to 40-minute sessions of music therapy with the presence of a trained music therapist were offered to participants. Results: In this study, 164 women were randomized and 116 (63 CG and 53 MTG) were included in the analyses, with mean age of 52.90 years (CG) and 51.85 years (MTG). Participants in the MTG had an average of 10 music therapy sessions, totaling 509 sessions throughout the study. FACT-F results were significant regarding Trial Outcome Index (P = .011), FACT-G (P = .005), and FACT-F (P = .001) for the MTG compared with the CG. Conclusions: Individual music therapy sessions may be effective to reduce fatigue related to cancer and symptoms of depression, as well as to improve quality of life for women with breast or gynecological cancer undergoing radiotherapy. Further well-designed research studies are needed to adequately determine the effects of music therapy on fatigue.
Relatamos as estratégias e os procedimentos adotados no desenvolvimento do Programa de musicoterapia para profissionais da saúde (PROMUS). A proposta insere-se no contexto das iniciativas ubimus que visam o incentivo ao bem-estar através da disponibilização e o estudo do impacto do suporte tecnológico em contextos cotidianos. Em particular, atentamos para a utilização de ambientes que previamente não eram considerados como espaços com potencialidade de aplicação musicoterapêutica. Outro aspecto inovador da presente proposta é o reaproveitamento de tecnologia já disponível nas atividades do dia a dia do público-alvo. Essa utilização de tecnologia leve, de baixo custo operativo e compatível com um perfil diverso de potenciais participantes está fortemente alinhada às práticas estabelecidas dentro da comunidade ubimus. Discutimos as implicações desta proposta para a ampliação do vínculo entre ubimus e os usos terapêuticos dos recursos musicais.
A doença de Parkinson (DP) é caracterizada, principalmente, por uma disfunção do sistema de gânglios basais, produzindo sintomas motores e não motores. O interesse pelo estudo da musicoterapia no tratamento auxiliar de pacientes com DP baseia-se em evidências científicas que comprovam que a música é capaz de melhorar a marcha e o comportamento dos pacientes. Tem por objetivo descrever os principais benefícios, efeitos e a influência da musicoterapia no tratamento auxiliar da DP, enfatizando a sua eficácia no parâmetro motor dos pacientes. Trata-se de uma revisão integrativa da literatura, com seleção dos estudos nas bases de dados Portal de Periódicos da Capes, PubMed, Scielo e SCOPUS, por meio dos Descritores em Ciências da Saúde (DeCS), nos idiomas português e inglês, no período de 2015 a 2021. De maneira geral, a terapêutica resultou na melhora do equilíbrio postural, bem como no aumento do comprimento do passo do paciente e no aumento da velocidade da marcha, o que levou a uma maior independência funcional, acarretando desfechos positivos na progressão da doença. A musicoterapia tem se tornado uma ferramenta com grande potencial para o tratamento auxiliar da doença de Parkinson. Esse instrumento tem proporcionado melhor qualidade de vida aos pacientes, aliviando os sintomas motores e não motores ao estimular a produção dopaminérgica.
Editorial para o dossê “Ubimus, Gastrossônica e Bem-estar” ocorrido de forma online em 2022 via Universidade Estadual do Paraná. Editores convidados: Damián Keller (Universidade Federal do Acre, Universidade Federal da Paraíba, Brasil), Tereza Raquel Alcântara-Silva (Universidade Federal de Goiás, Brasil), Bruno Mesz (Universidad Nacional de Tres de Febrero, Argentina)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.